Clinical Trials

Find a Trial

Trial Results

12 protocol(s) meet the specified criteria
B-016-001OPEN TO ACCRUAL
Clinical Assessment of Intraoperative Nerve Monitoring during Robot-assisted Laparoscopic Prostatectomy
C16-168OPEN TO ACCRUAL
A Randomized Phase II Trial of Abiraterone, Olaparib, or Abiraterone + Olaparib in Patients with Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects
CTMX-M-2009-001OPEN TO ACCRUAL
A Phase 1-2, Open-Label, Dose-Finding, Proof of Concept, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CX-2009 in Adults with Metastatic or Locally Advanced Unresectable Solid Tumors
GCP-10100OPEN TO ACCRUAL
Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients with Localized Prostate Cancer: a Prospective, Single-Arm, Pivotal Clinical Study
GU115/I6A-MC-CBBDOPEN TO ACCRUAL
A Double-Blinded, Placebo-Controlled, Randomized Phase II Study of Enzalutamide With or Without the PI3 Kinase/mTOR Inhibitor LY3023414 in Men with Metastatic Castration Resistant Prostate Cancer
IUSCC-0523OPEN TO ACCRUAL
Perioperative pelvic floor muscle training may improve recovery of continence in men with localized prostate cancer undergoing robot-assisted radical prostatectomy.
IUSCC-0581OPEN TO ACCRUAL
Photoacoustic Imaging in Human Prostate Cancer
IUSCC-0584OPEN TO ACCRUAL
COLLECTION OF SPECIMENS AND CLINICAL DATA TO CREATE A BIOREPOSITORY FOR THE GENITOURINARY ONCOLOGY PROGRAM
IUSCC-0588OPEN TO ACCRUAL
Glycosylation of exosomes in prostate and urothelial carcinoma
IUSCC-0634OPEN TO ACCRUAL
Detection of single nucleotide variants in circulating tumor DNA of patients with metastatic castration resistant prostate cancer
R-223OPEN TO ACCRUAL
Retrospective Analysis of Clinical Benefit from Radium 223 in Castrate Resistant Prostate Cancer
STU00077147OPEN TO ACCRUAL
Impact of Genetic Variants on Failure of Active Surveillance for Prostate Cancer